Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
Barrett, M S
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628. [electronic resource] - Diagnostic microbiology and infectious disease - 389-401 p. digital
Publication Type: Journal Article
0732-8893
10.1016/0732-8893(91)90066-o doi
Anti-Infective Agents
Bacteremia--microbiology
Ciprofloxacin--pharmacology
Drug Evaluation, Preclinical
Drug Resistance, Microbial
Enoxacin--pharmacology
Enterobacteriaceae--drug effects
Fleroxacin--pharmacology
Fluoroquinolones
Gram-Negative Bacteria--drug effects
Gram-Positive Bacteria--drug effects
Humans
Microbial Sensitivity Tests
Naphthyridines
Norfloxacin--pharmacology
Ofloxacin--pharmacology
Pseudomonas aeruginosa--drug effects
Quinolones--pharmacology
Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628. [electronic resource] - Diagnostic microbiology and infectious disease - 389-401 p. digital
Publication Type: Journal Article
0732-8893
10.1016/0732-8893(91)90066-o doi
Anti-Infective Agents
Bacteremia--microbiology
Ciprofloxacin--pharmacology
Drug Evaluation, Preclinical
Drug Resistance, Microbial
Enoxacin--pharmacology
Enterobacteriaceae--drug effects
Fleroxacin--pharmacology
Fluoroquinolones
Gram-Negative Bacteria--drug effects
Gram-Positive Bacteria--drug effects
Humans
Microbial Sensitivity Tests
Naphthyridines
Norfloxacin--pharmacology
Ofloxacin--pharmacology
Pseudomonas aeruginosa--drug effects
Quinolones--pharmacology